Advanced Filters
noise

Manhattan, New York Clinical Trials

A listing of Manhattan, New York clinical trials actively recruiting patient volunteers.

Found 2,284 clinical trials
M Matthew Amsden

Can EmeraldLED Reshape Your Body With Continued Use?

Already using EmeraldLED? TheGreen Light Therapy study explores how continuing participants' 15-minute sessions, twice a week, may continue to support positive changes in body composition.

18 years of age All Phase N/A
M Matthew Amsden

Chilipad Sleep Optimization Study

This study evaluates the Chilipad Dock Pro Bed Cooling System and Sleep Tracker, examining how bed temperature influences sleep quality and overall well-being.

years of age All Phase N/A

Gut Microbiome Pill

The purpose of this study is to evaluate the safety and efficacy of a 3D-printed ingestible pill designed to sample microbiota from the GI tract, focusing on the ability to collect data also from the small intestine. The study also aims to assess ease of use and transit time.

18 - 65 years of age All Phase N/A
M Matthew Amsden

Evaluating SleepWhale Drops for Rest & Resilience

30-day study evaluating SleepWhale Natural Sleep Drops (Extra Strength)-formulated to support deeper sleep and better days.

years of age All Phase N/A
A Amelia Adamska

Long-Term Efficacy and Duration of MFU-V at Multiple Depths and at 1.5 mm

The goal of this clinical trial is to evaluate the long-term safety and effectiveness of Ultherapy Prime (MFU-V) for improving lines, wrinkles, laxity, and crepiness of the lower face, submentum, and neck. The study will enroll adult male and female subjects aged 25-65 with moderate to severe lower-face and neck …

25 - 65 years of age All Phase N/A
R Rashmi Unawane

Imetelstat Combinations in Relapsed AML

IMAGINE is a two-part trial to evaluate the safety and preliminary efficacy of imetelstat in combination with azacitidine with or without venetoclax in patients with relapsed or refractory AML. The trial will consist of a safety run-in phase (Part A) employing a 3+3 design to monitor dose-limiting toxicities of imetelstat …

18 years of age All Phase 1
M Matthew Amsden

How Does Continued Use of Green Light Therapy Impact Outcomes?

Already using Green Light Therapy? Explore how continued use with twice-weekly 20-minute sessions may continue to support positive changes in body composition. Discover whether this non-invasive wellness approach gets better over time to help support energy, balance, and renewal.

18 years of age All Phase N/A
M Matthew Amsden

See the Impact Beem's Blue Light Therapy Has on Your Skin Health!

Participants will experience a rejuvenating twice-weekly light therapy journey that blends the power of blue, red, and infrared light. Each 20-minute session flows through three phases: starting with refreshing blue light to awaken and energize, then moving into soothing red light, and finishing with deeply nourishing infrared light. This unique …

years of age All Phase N/A
M Michael Bogenschutz, MD

Psilocybin for Opioid Use Disorder (OUD)

This is a double-blind, adaptive, 2-stage, multi-site, phase 2 randomized controlled clinical trial designed to evaluate effects of moderate and high dose psilocybin, relative to low-dose psilocybin control, in OUD patients who continue to use illicit opioids in spite of adherence to standard-of-care treatment with methadone. Up to 480 participations …

18 - 65 years of age All Phase 2
M Martha Cavallo, ANP

Safety and Pharmacokinetics Study of PGT121.414.LS Alone and in Combination With VRC07-523LS in Infants Exposed to HIV-1

The purpose of this study is to evaluate the safety and pharmacokinetics (PK) of the potent, broadly neutralizing anti-HIV monoclonal antibodies (mAb) PGT121.414.LS alone and in combination with VRC07-523LS soon after birth in infants exposed to HIV-1.

- 72 years of age All Phase 1

Simplify language using AI